245 related articles for article (PubMed ID: 31568233)
1. Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study.
Groenland SL; van Eerden RAG; Verheijen RB; Koolen SLW; Moes DJAR; Desar IME; Reyners AKL; Gelderblom HJ; van Erp NP; Mathijssen RHJ; Huitema ADR; Steeghs N
Ther Drug Monit; 2019 Oct; 41(5):561-567. PubMed ID: 31568233
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study.
Groenland SL; van Eerden RAG; Westerdijk K; Meertens M; Koolen SLW; Moes DJAR; de Vries N; Rosing H; Otten H; Vulink AJE; Desar IME; Imholz ALT; Gelderblom H; van Erp NP; Beijnen JH; Mathijssen RHJ; Huitema ADR; Steeghs N;
Ann Oncol; 2022 Oct; 33(10):1071-1082. PubMed ID: 35777707
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Drug Monitoring of Oral Anti-Hormonal Drugs in Oncology.
Groenland SL; van Nuland M; Verheijen RB; Schellens JHM; Beijnen JH; Huitema ADR; Steeghs N
Clin Pharmacokinet; 2019 Mar; 58(3):299-308. PubMed ID: 29862467
[TBL] [Abstract][Full Text] [Related]
4. Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies.
Widmer N; Bardin C; Chatelut E; Paci A; Beijnen J; Levêque D; Veal G; Astier A
Eur J Cancer; 2014 Aug; 50(12):2020-36. PubMed ID: 24928190
[TBL] [Abstract][Full Text] [Related]
5. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.
Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E
Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring of oral targeted antineoplastic drugs.
Mueller-Schoell A; Groenland SL; Scherf-Clavel O; van Dyk M; Huisinga W; Michelet R; Jaehde U; Steeghs N; Huitema ADR; Kloft C
Eur J Clin Pharmacol; 2021 Apr; 77(4):441-464. PubMed ID: 33165648
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Extrapolation Methods to Predict Trough Concentrations to Guide Therapeutic Drug Monitoring of Oral Anticancer Drugs.
Janssen JM; Dorlo TPC; Beijnen JH; Huitema ADR
Ther Drug Monit; 2020 Aug; 42(4):532-539. PubMed ID: 32384536
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring in cancer--are we missing a trick?
Bardin C; Veal G; Paci A; Chatelut E; Astier A; Levêque D; Widmer N; Beijnen J
Eur J Cancer; 2014 Aug; 50(12):2005-9. PubMed ID: 24878063
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics and therapeutic drug monitoring of anticancer agents].
Marquet P; Rousseau A
Bull Cancer; 2008 Oct; 95(10):903-9. PubMed ID: 19004719
[TBL] [Abstract][Full Text] [Related]
10. Imatinib, sunitinib and pazopanib: From flat-fixed dosing towards a pharmacokinetically guided personalized dose.
Westerdijk K; Desar IME; Steeghs N; van der Graaf WTA; van Erp NP;
Br J Clin Pharmacol; 2020 Feb; 86(2):258-273. PubMed ID: 31782166
[TBL] [Abstract][Full Text] [Related]
11. [Personalized medicine for oral molecular-targeted anticancer drugs].
Miura M
Nihon Yakurigaku Zasshi; 2019; 153(2):73-78. PubMed ID: 30745517
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review.
Cardoso E; Guidi M; Blanchet B; Schneider MP; Decosterd LA; Buclin T; Csajka C; Widmer N
Ther Drug Monit; 2020 Feb; 42(1):33-44. PubMed ID: 31479043
[TBL] [Abstract][Full Text] [Related]
14. On precision dosing of oral small molecule drugs in oncology.
Lyashchenko AK; Cremers S
Br J Clin Pharmacol; 2021 Feb; 87(2):263-270. PubMed ID: 32621551
[TBL] [Abstract][Full Text] [Related]
15. Applications and challenges in therapeutic drug monitoring of cancer treatment: A review.
Salman B; Al-Khabori M
J Oncol Pharm Pract; 2021 Apr; 27(3):693-701. PubMed ID: 33302823
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring in cancer chemotherapy.
Bach DM; Straseski JA; Clarke W
Bioanalysis; 2010 May; 2(5):863-79. PubMed ID: 21083218
[TBL] [Abstract][Full Text] [Related]
17. A framework for economic evaluation of therapeutic drug monitoring-guided dosing in oncology.
Erku D; Schneider J; Scuffham P
Pharmacol Res Perspect; 2021 Oct; 9(5):e00862. PubMed ID: 34546005
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of targeted anticancer therapy.
Decosterd LA; Widmer N; Zaman K; Cardoso E; Buclin T; Csajka C
Biomark Med; 2015; 9(9):887-93. PubMed ID: 26333311
[TBL] [Abstract][Full Text] [Related]
19. Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine.
Groenland SL; Mathijssen RHJ; Beijnen JH; Huitema ADR; Steeghs N
Eur J Clin Pharmacol; 2019 Sep; 75(9):1309-1318. PubMed ID: 31175385
[TBL] [Abstract][Full Text] [Related]
20. Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs.
Rousseau A; Marquet P
Fundam Clin Pharmacol; 2002 Aug; 16(4):253-62. PubMed ID: 12570013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
